Target intelligence / Profile preview

Medium-wave-sensitive opsin 3 (OPN1MW3)

Target
OPN1MW3
Molecular classification
G protein-coupled receptor (GPCR), Membrane protein, Photopigment
01

Overview

Medium-wave-sensitive opsin 3 (OPN1MW3) is a photopigment protein and member of the G protein-coupled receptor family, specifically expressed in cone photoreceptor cells of the retina that are responsible for detecting light in the middle wavelengths (green/yellow spectrum)[1][2][3]. It is one of several paralogs of the OPN1MW gene cluster on chromosome X and encodes an opsin protein that binds a retinal chromophore to enable color discrimination and light perception[1][5]. Mutations or rearrangements involving OPN1MW/OPN1MW3 cause X-linked red-green color vision deficiencies (deuteranopia, deuteranomaly), cone dystrophies, and are implicated in age-related macular degeneration[1][2][3]. OPN1MW3 is not considered a therapeutic drug target in current clinical use, and there are no marketed drugs designed to modulate its function. Notes on accuracy and conventions: - OPN1MW3 is not a commonly recognized or distinct clinical/therapeutic target; the canonical gene for human green opsin is OPN1MW. - OPN1MW3 is sometimes listed as a paralog or pseudogene, and most clinical/disease literature refers to OPN1MW, not OPN1MW3[2][3][5]. - The listing of OPN1MW3 is likely due to complex genomic arrangements and multiple gene copies; consequently, the “is_incorrect” flag is set to true because OPN1MW3 is not a standard, distinct therapeutic target and most validated functional disease associations reference the OPN1MW gene[1][2][3].

Other names
Medium-wave-sensitive opsin 3Green cone photoreceptor pigmentGreen-sensitive opsinGOPOpsin 1 cone pigments medium-wave-sensitive 3GCPOPN1MWOPN1MW2OPN1MW1M-pigmentphotopigment apoproteingreen cone pigmentmiddle-wave-sensitive pigmentOPSG_HUMAN
02

Mechanism of action

N/A (no known drugs targeting OPN1MW3 directly; general opsins interact with cis-retinal as chromophore for vision)

03

Biological functions

Signal transductionVision (phototransduction)Color visionResponse to light stimulus
04

Disease associations

Color vision deficiency (Red-green color blindness, deutan type)Cone dystrophyAge-related macular degenerationBlue cone monochromacy
05

Safety considerations

Not applicable (not a therapeutic target; gene therapy or diagnostics for color vision deficiency have potential safety/efficacy issues, but not specific to OPN1MW3)
06

Biomarkers

Deutan color vision deficiency (associated with OPN1MW/OPN1MW3 variants)

Beyond the preview

Go deeper on Medium-wave-sensitive opsin 3 (OPN1MW3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medium-wave-sensitive opsin 3 (OPN1MW3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call